Effects of Moderate Physical Activity on Early Symptoms of Peripheral Diabetic Neuropathy in Type-II Diabetes: A Randomized Clinical Trial
NCT ID: NCT05491850
Last Updated: 2022-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2021-10-01
2021-12-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Ankle Proprioception Training in Type 2 Diabetic Neuropathy
NCT05190198
Ankle Proprioceptive Training In Patients With Diabetic Peripheral Neuropathy
NCT05848180
Effects of Multisystem Exercise on Balance, Postural Stability, Mobility and Pain in Patients With DPN.
NCT06130917
Comparative Effects of Balance and Resisted Training in Diabetic Peripheral Neuropathy.
NCT06303453
Combined Effects of Foot-Ankle Therapeutic Exercises and Mindful Walking in Patients With Diabetic Polyneuropathy
NCT07248631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moderate Physical Activity Group
The Experimental Group gets moderate physical activity. Elliptical will be performed at least 5 days/per week. Moderate intensity, corresponding approximately to 40-60% of Vo2max (maximal aerobic capacity) 150 min/week of exercise undertaken at moderate intensity or greater. Warm-up and Dynamic stretching is given before and static stretching is given after moderate physical activity.
Moderate Physical Activity for Peripheral Diabetic Neuropathy
Moderate physical activity can increase movement and heart rate are particularly important for people suffering with peripheral neuropathy. Physical activity can improve blood circulation, which strengthens nerve tissues by increasing the flow of oxygen.
Non Specific Physical Activity Group
The Control group continues their regular medication for diabetic neuropathy.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moderate Physical Activity for Peripheral Diabetic Neuropathy
Moderate physical activity can increase movement and heart rate are particularly important for people suffering with peripheral neuropathy. Physical activity can improve blood circulation, which strengthens nerve tissues by increasing the flow of oxygen.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed cases of Peripheral Diabetic Neuropathy
* Peripheral Diabetic Neuropathy Stage 1 \& 2
* Numbness or reduced ability to feel pain or temperature changes.
* Tingling or burning sensation.
* Sharp pains or cramps.
* Increased sensitivity to touch
* Males and females
* Age: 35-65
* HbA1c above 6.5
* Mild activity level on IPAQ-7 (\< 150min/per week)
* Berg Balance Scale score (\< 45)
Exclusion Criteria
* Any neurological issue
* Lower limb deformity
* Acute injury
* Hip and Knee OA
* Patients with walking difficulty
* Diabetic foot
35 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Waqar Ahmed Awan
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RHS Rehabilitation Center
Islamabad, Federal, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIPHAH/FR&AHS/Letter-0985
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.